Record Information |
---|
Version | 5.0 |
---|
Status | Detected but not Quantified |
---|
Creation Date | 2021-09-11 13:36:38 UTC |
---|
Update Date | 2021-09-26 23:08:17 UTC |
---|
HMDB ID | HMDB0254349 |
---|
Secondary Accession Numbers | None |
---|
Metabolite Identification |
---|
Common Name | Mavacoxib |
---|
Description | mavacoxib, also known as pha 739,521, belongs to the class of organic compounds known as phenylpyrazoles. Phenylpyrazoles are compounds containing a phenylpyrazole skeleton, which consists of a pyrazole bound to a phenyl group. Based on a literature review a significant number of articles have been published on mavacoxib. This compound has been identified in human blood as reported by (PMID: 31557052 ). Mavacoxib is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically Mavacoxib is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
---|
Structure | NS(=O)(=O)C1=CC=C(C=C1)N1N=C(C=C1C1=CC=C(F)C=C1)C(F)(F)F InChI=1S/C16H11F4N3O2S/c17-11-3-1-10(2-4-11)14-9-15(16(18,19)20)22-23(14)12-5-7-13(8-6-12)26(21,24)25/h1-9H,(H2,21,24,25) |
---|
Synonyms | Value | Source |
---|
Mavacoxibum | ChEBI | PHA 739,521 | ChEBI | PHA-739521 | ChEBI | 4-(5-(4-Fluorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide | MeSH |
|
---|
Chemical Formula | C16H11F4N3O2S |
---|
Average Molecular Weight | 385.34 |
---|
Monoisotopic Molecular Weight | 385.050810432 |
---|
IUPAC Name | 4-[5-(4-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzene-1-sulfonamide |
---|
Traditional Name | mavacoxib |
---|
CAS Registry Number | Not Available |
---|
SMILES | NS(=O)(=O)C1=CC=C(C=C1)N1N=C(C=C1C1=CC=C(F)C=C1)C(F)(F)F |
---|
InChI Identifier | InChI=1S/C16H11F4N3O2S/c17-11-3-1-10(2-4-11)14-9-15(16(18,19)20)22-23(14)12-5-7-13(8-6-12)26(21,24)25/h1-9H,(H2,21,24,25) |
---|
InChI Key | TTZNQDOUNXBMJV-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as phenylpyrazoles. Phenylpyrazoles are compounds containing a phenylpyrazole skeleton, which consists of a pyrazole bound to a phenyl group. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Azoles |
---|
Sub Class | Pyrazoles |
---|
Direct Parent | Phenylpyrazoles |
---|
Alternative Parents | |
---|
Substituents | - Phenylpyrazole
- Benzenesulfonamide
- Benzenesulfonyl group
- Fluorobenzene
- Halobenzene
- Aryl fluoride
- Aryl halide
- Monocyclic benzene moiety
- Benzenoid
- Organosulfonic acid amide
- Heteroaromatic compound
- Organic sulfonic acid or derivatives
- Organosulfonic acid or derivatives
- Aminosulfonyl compound
- Sulfonyl
- Azacycle
- Organosulfur compound
- Organonitrogen compound
- Organofluoride
- Organohalogen compound
- Alkyl fluoride
- Hydrocarbon derivative
- Organic oxide
- Organopnictogen compound
- Alkyl halide
- Organic nitrogen compound
- Organic oxygen compound
- Aromatic heteromonocyclic compound
|
---|
Molecular Framework | Aromatic heteromonocyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Mavacoxib,1TMS,isomer #1 | C[Si](C)(C)NS(=O)(=O)C1=CC=C(N2N=C(C(F)(F)F)C=C2C2=CC=C(F)C=C2)C=C1 | 2745.4 | Semi standard non polar | 33892256 | Mavacoxib,1TMS,isomer #1 | C[Si](C)(C)NS(=O)(=O)C1=CC=C(N2N=C(C(F)(F)F)C=C2C2=CC=C(F)C=C2)C=C1 | 2806.5 | Standard non polar | 33892256 | Mavacoxib,1TMS,isomer #1 | C[Si](C)(C)NS(=O)(=O)C1=CC=C(N2N=C(C(F)(F)F)C=C2C2=CC=C(F)C=C2)C=C1 | 3368.5 | Standard polar | 33892256 | Mavacoxib,2TMS,isomer #1 | C[Si](C)(C)N([Si](C)(C)C)S(=O)(=O)C1=CC=C(N2N=C(C(F)(F)F)C=C2C2=CC=C(F)C=C2)C=C1 | 2764.7 | Semi standard non polar | 33892256 | Mavacoxib,2TMS,isomer #1 | C[Si](C)(C)N([Si](C)(C)C)S(=O)(=O)C1=CC=C(N2N=C(C(F)(F)F)C=C2C2=CC=C(F)C=C2)C=C1 | 2969.4 | Standard non polar | 33892256 | Mavacoxib,2TMS,isomer #1 | C[Si](C)(C)N([Si](C)(C)C)S(=O)(=O)C1=CC=C(N2N=C(C(F)(F)F)C=C2C2=CC=C(F)C=C2)C=C1 | 3306.6 | Standard polar | 33892256 | Mavacoxib,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)NS(=O)(=O)C1=CC=C(N2N=C(C(F)(F)F)C=C2C2=CC=C(F)C=C2)C=C1 | 2993.3 | Semi standard non polar | 33892256 | Mavacoxib,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)NS(=O)(=O)C1=CC=C(N2N=C(C(F)(F)F)C=C2C2=CC=C(F)C=C2)C=C1 | 3042.5 | Standard non polar | 33892256 | Mavacoxib,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)NS(=O)(=O)C1=CC=C(N2N=C(C(F)(F)F)C=C2C2=CC=C(F)C=C2)C=C1 | 3365.7 | Standard polar | 33892256 | Mavacoxib,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N([Si](C)(C)C(C)(C)C)S(=O)(=O)C1=CC=C(N2N=C(C(F)(F)F)C=C2C2=CC=C(F)C=C2)C=C1 | 3282.4 | Semi standard non polar | 33892256 | Mavacoxib,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N([Si](C)(C)C(C)(C)C)S(=O)(=O)C1=CC=C(N2N=C(C(F)(F)F)C=C2C2=CC=C(F)C=C2)C=C1 | 3402.9 | Standard non polar | 33892256 | Mavacoxib,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N([Si](C)(C)C(C)(C)C)S(=O)(=O)C1=CC=C(N2N=C(C(F)(F)F)C=C2C2=CC=C(F)C=C2)C=C1 | 3335.3 | Standard polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Mavacoxib GC-MS (Non-derivatized) - 70eV, Positive | splash10-00xr-1759000000-4a5954b81545be15d73f | 2021-09-24 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Mavacoxib GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Mavacoxib 10V, Positive-QTOF | splash10-000i-0009000000-93db0270308b80395089 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Mavacoxib 20V, Positive-QTOF | splash10-000i-0009000000-74bcbaabd2a3a1e8d7e4 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Mavacoxib 40V, Positive-QTOF | splash10-001i-0489000000-58549e1170368ed3d63e | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Mavacoxib 10V, Negative-QTOF | splash10-001i-0009000000-0782cb202e93036e4dd8 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Mavacoxib 20V, Negative-QTOF | splash10-00lr-4009000000-26a8ac11fd01521bfbba | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Mavacoxib 40V, Negative-QTOF | splash10-014i-9001000000-a5ba0faa82ff858e327f | 2021-10-12 | Wishart Lab | View Spectrum |
|
---|